| scholarly article | Q13442814 |
| P2093 | author name string | Xue Xiao | |
| Gong Yang | |||
| Jinsong Liu | |||
| Xi Cheng | |||
| Xiaohua Wu | |||
| Imelda Mercado-Uribe | |||
| Xiang Du | |||
| Daniel G Rosen | |||
| Bin Chang | |||
| Paul Chiao | |||
| Guangzhi Liu | |||
| Fengxia Xue | |||
| P2860 | cites work | Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation | Q24316905 |
| Nucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosis | Q28182225 | ||
| Identification and characterization of an IkappaB kinase | Q28245341 | ||
| Good cop, bad cop: the different faces of NF-kappaB | Q28291669 | ||
| Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma | Q28474516 | ||
| Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin | Q28476078 | ||
| Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination | Q28615601 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation | Q29614709 | ||
| Regulation and function of NF-kappaB transcription factors in the immune system | Q29616427 | ||
| Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer | Q33387721 | ||
| Control of apoptosis by Rel/NF-kappaB transcription factors | Q33797163 | ||
| Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer | Q33862932 | ||
| CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis | Q34095143 | ||
| Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer | Q34159472 | ||
| Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin | Q34574584 | ||
| The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis | Q35133880 | ||
| Nuclear factor-kappaB: the enemy within | Q35893620 | ||
| NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis | Q35971557 | ||
| Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma | Q37428076 | ||
| Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells | Q38308753 | ||
| Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells. | Q40396768 | ||
| NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. | Q40431585 | ||
| Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer | Q40438108 | ||
| Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models | Q40486780 | ||
| Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
| Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells. | Q40527525 | ||
| Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. | Q40571746 | ||
| Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models | Q40577628 | ||
| Collagenase expression in ovarian cancer cell lines | Q41119331 | ||
| Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. | Q41573546 | ||
| Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling | Q42475218 | ||
| DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells | Q43725270 | ||
| IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines | Q43830219 | ||
| NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. | Q45982548 | ||
| Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma | Q46154672 | ||
| CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis | Q46492957 | ||
| ARF the integrator: linking NF-kappaB, p53 and checkpoint kinases | Q46560525 | ||
| Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer | Q46681064 | ||
| NF-kappaB signaling. Many roads lead to madrid. | Q52601425 | ||
| Vitamin E supplementation does not alter azoxymethane-induced colonic aberrant crypt foci formation in young or old mice. | Q53382930 | ||
| Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis. | Q53615123 | ||
| Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. | Q54033436 | ||
| Role of NF-κB in p53-mediated programmed cell death | Q57248006 | ||
| p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor | Q58287158 | ||
| Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development | Q74463183 | ||
| Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1 | Q79929599 | ||
| X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 | ||
| NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta | Q82579230 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| ovarian cancer | Q172341 | ||
| P304 | page(s) | 2181-2194 | |
| P577 | publication date | 2011-02-21 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer | |
| P478 | volume | 17 |
| Q38701979 | A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer. |
| Q28397767 | Acute toxicity of nickel nanoparticles in rats after intravenous injection |
| Q37636771 | Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells |
| Q51786825 | Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression. |
| Q90568296 | CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer |
| Q54982028 | CDK5RAP1 targeting NF-κB signaling pathway in human malignant melanoma A375 cell apoptosis. |
| Q42923164 | Caspase 8 expression may determine the survival of women with ovarian cancer |
| Q36426504 | Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway. |
| Q35953034 | Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models |
| Q39217797 | Effects of peroxisome proliferator-activated receptor-γ activation on apoptosis in rats with acute pancreatitis |
| Q34365776 | Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling. |
| Q60932036 | Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo |
| Q36097337 | Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways |
| Q99711837 | Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis |
| Q33589182 | Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway |
| Q61811267 | Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT/NF-κB pathway |
| Q37901473 | Focus on skin cancer association and progression under TNF antagonist therapy |
| Q38950425 | Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer |
| Q37351339 | Generation of cancer stem-like cells through the formation of polyploid giant cancer cells |
| Q37148431 | Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway |
| Q64238152 | Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy |
| Q38863540 | Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells |
| Q38822902 | Low-dose rotenone exposure induces early senescence leading to late apoptotic signaling cascade in human trabecular meshwork (HTM) cell line: An in vitro glaucoma model |
| Q26786151 | NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis |
| Q92823981 | NF-κB Signaling in Ovarian Cancer |
| Q35095325 | NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression |
| Q64998338 | NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin. |
| Q37309839 | NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. |
| Q47598471 | NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells. |
| Q38226577 | Oncogenes associated with drug resistance in ovarian cancer |
| Q89186003 | Optimization Of Cancer Treatment Through Overcoming Drug Resistance |
| Q36391394 | Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells |
| Q33761535 | Poor survival with wild-type TP53 ovarian cancer? |
| Q38741073 | Recently identified drug resistance biomarkers in ovarian cancer |
| Q37297766 | Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K/AKT and MAPK pathways |
| Q37570392 | Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. |
| Q39123683 | Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study |
| Q35056554 | TLR4 activates NF-κB in human ovarian granulosa tumor cells |
| Q40751673 | Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. |
| Q53406743 | The Major Role of NF-kB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells. |
| Q90617431 | The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy |
| Q37976939 | The diverse and complex roles of NF-κB subunits in cancer |
| Q35931850 | The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer |
| Q38802627 | Transcription Factor NF-κB: An Update on Intervention Strategies |
| Q36789013 | VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer |
Search more.